Similar to TDEs, renal cancer TDE-anchored IL-12 (EXO/IL-12) also provides a much smaller reduction in p-STAT5 expression but has the same inhibitory effect on JAK3, but not on JAK2. This evidence concerns the gene JAK2 and renal carcinoma.